Table 2.
Percentage of Oct4+/Nanog+ hPSCs vs. passage number during long-term direct culture with bFGF-MCMs.
| Passage # | P6 | P10 | P20 | P25 |
|---|---|---|---|---|
| H1 hESC | 98.8% | 95.6% | 94.7% | 95.0% |
| WTc11 hiPSC | 96.8% | 92.4% | 93.1% | 92.9% |
Percentage of Oct4+/Nanog+ hPSCs vs. passage number during long-term direct culture with bFGF-MCMs.
| Passage # | P6 | P10 | P20 | P25 |
|---|---|---|---|---|
| H1 hESC | 98.8% | 95.6% | 94.7% | 95.0% |
| WTc11 hiPSC | 96.8% | 92.4% | 93.1% | 92.9% |